^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SHR-A2102

    i
    Other names: SHR-A2102
    Company:
    Jiangsu Hengrui Pharma
    Drug class:
    Nectin-4-targeted antibody-drug conjugate
    Related drugs:
    12ms
    Phase I Study of SHR-A2102 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=200, Recruiting, Shanghai Hengrui Pharmaceutical Co., Ltd. | Not yet recruiting --> Recruiting
    Enrollment open • Metastases
    |
    SHR-A2102